6th Gene Therapy Analytical Development and CMC Summit
Evvnt Promotion / evvnt
Archivo
30.10.2024 - 01.11.2024 The Westin Copley Place, 10 Huntington Ave, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temas de la conferencia
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
URL:
Brochure: https://go.evvnt.com/2481285-3?pid=4832
Speakers: Luke Arbogast Director, R and D Eli Lilly, Surya Addepalli Scientist, Gene Therapy Research BioMarin, Steven Berkowitz Consultant Pacira , and more
Información e inscripción:
https://go.evvnt.com/2481285-2?pid=4832
Ms. Karina Bikerniece
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
